17 Traumatic spinal cord injury (SCI) has devastating implications for patients, including a high 18 predisposition for developing chronic pain distal to the site of injury. Chronic pain develops weeks 19 to months after injury, consequently patients are treated after irreparable changes have occurred. 20
begin to address how peripheral sensory neurons distal to the site of injury may contribute to the 23 below-level pain reported by SCI patients, we examined SCI-induced changes in gene expression 24 in lumbar dorsal root ganglia (DRG) below the site of injury. SCI was performed at the T10 25 vertebral level, with injury produced by a vessel clip with a closing pressure of 15g for 1 minute. 26 Alterations in gene expression produce long-term sensory changes, therefore we were interested 27 in studying SCI-induced transcripts before the onset of chronic pain, which may trigger changes 28 in downstream signaling pathways and ultimately facilitate the transmission of pain. To examine 29 changes in the nociceptor subpopulation in DRG distal to the site of injury, we retrograde labeled 30 sensory neurons projecting to the hairy hindpaw skin with fluorescent dye and collected the 31 corresponding lumbar (L2-L6) DRG 4 days post-injury. Following dissociation, labeled neurons 32
were purified by fluorescence-activated cell sorting. RNA was extracted from sorted sensory 33 neurons of naïve, sham, or SCI mice and sequenced. Transcript abundances validated that the 34 desired population of nociceptors were isolated. Cross-comparisons to data sets from similar 35 studies confirmed we were able to isolate our cells of interest and identify a unique pattern of gene 36 expression within a subpopulation of neurons projecting to the hairy hindpaw skin. Differential 37 gene expression analysis showed high expression levels and significant transcript changes 4 days 38 post-injury in SCI cell populations relevant to the onset of chronic pain. Regulatory 39 interrelationships predicted by pathway analysis implicated changes within the synaptogenesis 40 signaling pathway as well as networks related to inflammatory signaling mechanisms, suggesting 41 a role for synaptic plasticity and a correlation with pro-inflammatory signaling in the transition 42 from acute to chronic pain. 43 44 45
Considerable advances have been made in understanding changes within the spinal cord, including 74 how spinally mediated alterations contribute to SCI-induced pain by increasing spinal cord 75 excitability, and by establishing a variety of factors that impact how incoming sensory stimulation 76 is processed (Bruce et al. 2002 , Meisner et al. 2010 , You et al. 2008 ). However, this approach has 77 not translated into successful pain management. This may be attributed to an incomplete 78 understanding of the differential functions of specific afferent subtypes in SCI, and how afferents 79 distal to the site of injury become sensitized in patients with chronic below-level pain (Thakur et 80 al. 2014 ). The sensory system receives inputs from multiple cell types, and peripheral cell bodies 81 within the dorsal root ganglion (DRG) are important targets for assessing sensory function and 82 pain (Usoskin et al. 2015) . Persistent activity from injured and non-injured afferent fibers 83 contributes to development and maintenance of chronic pain following SCI (Gold and Gebhart 84 2010). 85
Each sensory neuron has a unique pattern of gene expression that influences its modality-specific 86 contribution to injury-induced pain (Le Pichon and Chesler 2014). To better understand the 87 underlying pathophysiology of below-level pain following SCI, it is necessary to identify changes 88 in cells impacted by the injury. The skin is heavily innervated by a broad range of nociceptors, and 89 previous work has shown that SCI can impact the function of cutaneous nociceptors below the 90 level of injury (Berta et al. 2017 ). This has been demonstrated by sustained spontaneous activity 91 in peripheral terminals and in cell bodies of sensory neurons projecting to the skin after initial SCI 92 (Bedi et Additional work has demonstrated that blockade of peripheral afferents into the central nervous 94 system can effectively mitigate patient discomfort and chronic pain (Basbaum et al. 2009, 95 Campbell et al. 1988, Gold and Gebhart 2010) . These data support the idea that the mechanisms 96 generating and maintaining prolonged pain reside within the peripheral nervous system. 97 98
In the present study, we identify specific transcriptional alterations in non-injured DRG distal to 99 the site of injury. Using retrograde labeling from hairy hindpaw skin and flow cytometry, we 100 isolated a nociceptor population projecting to sites distal to the spinal injury, free of surrounding 101 neuronal and glial cells. This enabled identification of novel cutaneous nociceptor genes and 102 predicted pathways not discernible by whole DRG tissue analyses. 103 104
Methods 105
Animals. Experiments were conducted with adult (8-12 week) female C57BL/6J mice (Jackson 106
Laboratory, Bangor ME). Several chronic pain conditions have a higher prevalence in females, 107 and numerous studies have reported higher pain prevalence in the SCI population among female 108 patients (Cardenas et al. 2004 ). Women also report greater frequency, severity, and longer lasting 109 pain, as well as neuropathic pain below the level of injury, in comparison to men (Cardenas, Bryce, 110 Shem, Richards and Elhefni 2004). The majority of research examines SCI in male rodents and 111 this study will add to what is known in the literature by focusing on female mice (Cardenas, Bryce, 112 Shem, Richards and Elhefni 2004). Naïve animals were group housed; sham and spinal cord 113 injured animals were individually caged. All animals were maintained on a 12:12-h light-dark 114 cycle with a temperature-controlled environment, and given food and water ad libitum. All 115 treatments and testing were approved by the University of Connecticut Health Center Institutional 116
Animal Care and Use Committee. 117 118
Spinal cord injury (SCI) procedure. Animals were anesthetized by inhalation of isoflurane and 119 a 1.0-cm dorsal midline skin sterile incision was made over T8-T11, as per Ma et al. ( Mechanical sensitivity. To assess mechanical sensitivity, mice were confined in clear plastic 154 containers placed on an elevated wire mesh platform. Prior to testing, mice were acclimated to the 155 apparatus for 60 minutes. Mechanical reactivity was assessed on the plantar surface of the hind 156 paw using a series of calibrated von Frey filaments according to the up-down method as described 157 (Dixon 1980) , and 50% response thresholds were compared across all conditions. Both hindpaws 158
were tested for mechanical sensitivity, and collapsed across each group of mice per condition. 159
Mice were tested for mechanical hypersensitivity 1 day prior to surgery for baseline response 160 thresholds, and at days 1, 3, 5, and 7 post-surgery. N=6 Software, San Diego, CA). R studio was utilized for differential expression analysis; Prism 287
software was used for all other statistical tests. 288 289
Results 290
Characterization of behavioral and inflammatory phenotypes of sham mice. To determine an 291 optimal time point to observe transcriptional changes contributing to the transition from acute to 292 chronic pain, we tested behavioral differences between naïve and sham operated mice. This was 293
to ensure that changes within the DRG were due to injury to the spinal cord itself, not to the 294 laminectomy performed in both injured and sham mice. Specifically, we tested naïve and sham 295 mice for open field locomotor differences 1, 3, 5, and 7 days post-surgery ( Fig.1A1 ). Naïve and 296
sham mice did not differ significantly at any of the time points tested, including as early as 1 day 297 post-surgery. To ensure that SCI mice (T10 compression-clip injury) did exhibit behavioral 298 differences and locomotor deficits following injury, we compared SCI mice to naïve and sham 299 mice for open field behavior 1 day post-injury ( Fig.1A2 ). SCI mice exhibited substantially 300 decreased total ambulation (one-way ANOVA, p=0.0059, Tukey's multiple comparisons test, 301 naïve **p<0.005, sham *p<0.05) following injury, as expected, although time spent in the 302 periphery did not differ (Suppl.1A). Additional tests for mechanical (von Frey) and thermal (hot 303 water tail-flick) hypersensitivity showed that naïve and sham conditions did not differ significantly 304 at any time point ( Fig.1B ). We did not examine SCI mice for thermal or mechanical sensitivity, as 305 paralysis below the level of injury prohibited below-level sensitivity testing and previous work 306
using the clip-compression model has not demonstrated significant changes in above-level 307 sensitivity following SCI (Bruce, Oatway and Weaver 2002). The development of chronic pain at 308 later time points following clip-compression models of SCI (in addition to several other models) 309
has already been well characterized. Therefore we focused on early time points after injury, to 310 identify contributions to the onset of pain, rather than changes after chronic pain has already 311 developed ( Previous work has highlighted the importance of inflammatory cytokines within the CNS to 314 facilitate the transduction of noxious stimuli in neuropathic pain (Cook et al. 2018 ). Thus, we 315 examined post-surgical changes in inflammation, using ELISAs to analyze common cytokine 316 markers to ensure that sham mice did not differ significantly from naïve mice following the 317 removal of bone and muscle. We did not observe significant differences in inflammatory cytokine 318 levels (TNF-α, IL-6, IL-1β, IL-10) in extracts of spinal cord segments (T8-T11) in naïve or sham 319 mice at 1, 4, 5, and 7 days post-surgery ( Fig.1C, Suppl.1B) . Spinal cords from SCI mice had 320 significantly increased levels of IL-6 and IL-10 in comparison to naïve controls (one-way 321 ANOVA, Bonferroni's multiple comparisons test; *p<0.05, **p<0.005, respectively). When 322 compared to sham conditions, spinal cords from SCI mice had significantly increased levels of IL-323 10 in comparison to 4d, 5d, and 7d sham conditions (one-way ANOVA, Bonferroni's multiple 324 comparisons test; ***p<0.001, **p<0.005, , **p<0.005, respectively. As a positive control, we 325 tested cuprizone-treated mice (a model of multiple sclerosis), which are known to secrete 326 proinflammatory cytokines at the end of 5 weeks of treatment (Mukhamedshina et al. 2017 ). 327
Cuprizone-treated mice showed expected increases in levels of TNF-α, IL-1β, and IL-10 in 328 comparison to naïve controls (one-way ANOVA, Bonferroni's multiple comparisons test; 329 *p<0.05, **p<0.005, **p<0.005, respectively) (Schmitz and Chew 2008) . Similarly, in 330 comparison to sham mice, spinal cord extracts from cuprizone-treated mice had significant 331 increases in IL-1β at the 1d sham timepoint, and IL-10 at the 4d, 5d, and 7d sham timepoints (one-332 way ANOVA, Bonferroni's multiple comparisons test; *p<0.05, ****p<0.0001, **p<0.005, 333 ***p<0.001, respectively). Behavioral testing and cytokine analyses did not reveal differences 334 between naïve and sham mice at any time point. 335 336
Confirmation of cell population specific labeling of cutaneous nociceptors. Because the 337 laminectomy did not significantly affect behavior or inflammatory responses in sham mice, we 338 determined an optimal time point to study the transition of acute to chronic pain based upon 339 established characteristics of nociceptors following SCI. The inflammatory cytokine assays 340 demonstrated that SCI causes major inflammation compared to sham controls at 4d after injury 341 (Fig.1C, Suppl.1B ). In addition, previous studies have documented onset of spontaneous activity 342 in nociceptors distal to the site of SCI as early as 3 days post-injury; increased activity persisted 343 for at least 8 months (Bedi, Yang, Crook, Du, Wu, Fishman, Grill, Carlton and Walters 2010 To perform transcriptional profiling on nociceptors that project to the cutaneous skin after injury, 351
we injected wheat germ agglutinin conjugated to an AF-488 dye (WGA-488) into the sural, 352 common peroneal, and saphenous nerve skin territories for retrograde labeling of DRG neurons. 353
Next, we performed compression-clip SCI or sham surgeries at the T10 vertebral level 2 days post-354
WGA injection, and collected L2-L6 DRG for dissociation 4 days post-injury ( Fig.2A ). Based on 355
the vertebral level at which we performed SCI, the DRG collected were located below the level of 356 injury, thus our analysis was comprised of non-injured nociceptors that do not project directly to 357 the lesion site. Flow cytometry confirmed that our cell population of interest (cutaneous 358 nociceptors) was positively labeled with WGA-488 ( Fig.2B ). We also observed non-labeled 359
(WGA-488) cells and dead cells (propidium iodide, PI+), to be excluded from cell sorting and 360 analysis ( Fig. 2B) . As expected, a significant number of viable small nociceptor cells were 361 excluded in this analytical approach, to avoid including RNAs from non-nociceptor cells or 362 attached fragments of dead cells (examples in Fig. 2C ) ( projections to the hairy hind paw skin. DRG cells were enzymatically dissociated and subjected to 370 flow cytometry, to gently isolate positively labeled cells between 10 and 30μm; propidium iodide 371 staining was used to identify dead cells. All conditions were gated on DRG from naïve mice that 372 did not receive WGA-488 injections, enabling purification of positively labeled cells ( Fig.3A ). 373
Analysis of our flow cytometry data shows that we were successful in retrogradely labeling DRG 374 neurons projecting to hairy hind paw skin. Many positively labeled neurons were part of cell 375
aggregates, limiting retrieval of the single cell population of interest to ~2% of all dissociated cells 376 per animal (Fig.3B ). This percentage amounted to approximately 3,000 cells per mouse, a suitable 377
representation of this cell population in agreement with previous studies ( were all expressed at high levels. High expression levels were also observed for transcripts of the 424 two major subpopulations of nociceptors; peptidergic and non-peptidergic ( Fig.4D ). 425 426
Gene expression profiling and enrichment patterns in injured and non-injured cutaneous 427 nociceptors after SCI. To further assess expression profiles of the purified nociceptor population 428 and differences among naïve, sham, and SCI conditions within this nociceptor-enriched 429 We focused on expression patterns of gene families which mediate neuronal functions and 440 contribute to pain phenotypes, and found both high expression levels and significant differences 441 within the chloride channel family, Trp channels, glutamate receptors, GABA receptors, potassium 442 channels, sodium channels, and piezo channels ( Fig.5A-G To better characterize enriched genes within our population, we graphed the expression of the 25 491 most significantly enriched genes in our data set in comparison to the same data sets used for 492 hierarchical clustering (Fig. 6B) . While many of the genes have similarly high expression levels, 493 several genes were unique to our isolated population, including Dgkh (diacylglycerol kinase), 494
Ank2 (ankyrin 2), Phf24 (PHD finger protein 24), Srrm2 (serine/arginine repetitive matrix 2), Fasn 495 (fatty acid synthase), Pirt (phosphoinositide-interacting regulator of transient receptor potential 496 channels), and Plekha6 (pleckstrin homology domain containing, family A member 6). We also 497 compared the expression pattern of our naïve nociceptor-enriched population to the various 498 datasets by again examining known neuronal markers of somatosensation ( Fig. 6C) . As predicted, 499 all of the sorted populations exhibit relatively high expression levels of gene transcripts associated 500 with thermosensation, nociception, or neurotrophic receptors, and comparatively low levels of 501 genes associated with itch, tactile function, or proprioception. It is evident that our cutaneous, 502
nociceptor-enriched population can be defined by its distinct gene expression patterns, in particular 503 high expression levels of the Trp family of genes listed in Fig. 6C , as well as Ntrk2, Ntrk3, and 504
Gfra3 neurotrophic receptors. 505 506
Ingenuity pathway analysis (IPA) identified significantly different canonical pathways from 507 cutaneous nociceptors after SCI. Based on DESeq2 analysis, levels of several hundred 508 transcripts in the nociceptor-enriched population were altered by SCI. We restricted IPA input lists 509
to genes that had RPKM values greater than 10 and were statistically different (SCI vs. Naïve or 510 SCI vs. Sham) by DESeq2 analysis (Fig.7A, B) . Transcripts that exhibited large fold changes 511
included Mrgprb5, Hal, Chrnb4, Cap2, Sez6l, Calb1, Prokr2, Rxfp1, Nxpe2, and Arap3 (Fig.7A,  512  B) . These genes did not appear in any common significant canonical pathways. IPA identified 513 several pathways that are considered important for inflammatory processes, pain transduction, or 514 the maintenance of chronic pain (Fig.7C ). This includes calcium signaling, Cxcr4 signaling, 515 neuropathic pain signaling in dorsal horn neurons, opioid signaling, purinergic receptor signaling 516 and synaptic long term potentiation (Fig.7C ) ( 2018). The current study focused on significant changes due to SCI pain and not due to post-518 surgical pain (i.e. changes between sham vs. naïve groups). 519 520
Validation of RNASeq data using qPCR. We used qPCR to confirm changes in transcripts of 521 interest from our RNAseq data set. To validate qPCR and RNAseq comparisons, we compared 522 qPCR or RPKM Log2 transcript levels of SCI and sham genes of interest (Fig.7D ). SCI and sham 523 qPCR fold change results were analogous to the RNAseq fold change data set. We focused on the 524 synaptogenesis pathway in particular, as it includes several genes present in overlapping canonical 525 pathways, including changes in receptors involved in organization of excitatory signaling (Ephb) 526 and synapses which may be involved in development of chronic pain (TrkB and BDNF). We 527 validated receptors for significant genes in the synaptogenesis pathway, and genes considered 528 possible contributors to pain that also showed significant differences between conditions Gabrg3, 529
Il6st Willis and Hulsebosch 2009). However, other studies have asserted that operant behavioral tasks, 558 such as conditioned place preference, are required to effectively study below-level pain in animals 559 (Yezierski 2005) . The present study focused on the transition from acute to chronic pain, in the 560 absence of early pain-related behavior, to examine transcriptional differences that occur at much 561 earlier time points rather than a point at which chronic pain is already present. We first tested 562 behavioral differences between naïve and sham mice to identify changes due to the laminectomy, 563 not the spinal cord injury itself, to better determine a time point that captures the transition from 564 acute to chronic pain following SCI. For example, removal of bone and muscle alone could trigger 565 chronic pain-like symptoms, analogous to post-surgical pain reported in humans (Woolf 2011). 566 Surprisingly, there were no significant differences between naïve and sham mice at any time point 567 (Fig.1A, B) , suggesting that the laminectomy did not produce any locomotor differences or 568 behavioral hypersensitivity 1-7 days post-surgery in mice. By contrast, the spinal cord injury 569 produced clear locomotor differences (Fig.1A2 ). 570 571
Injury and inflammation in SCI 572
We also considered post-surgical inflammation, using cytokine ELISAs to assess changes in the 573 spinal cord at the level of laminectomy (T8-T11). We wanted to assess changes in cytokine levels 574 for two main reasons; firstly, to confirm that sham mice did not exhibit differences from naïve 575 mice at key timepoints in comparison to SCI mice, and secondly to determine whether sham mice 576 exhibited a prolonged inflammatory response, which could potentially be correlated to the 577 development of chronic pain (Krames 2014 ). Both pro-inflammatory cytokines TNF-α and IL-1β 578 have been studied in neuroprotection models of SCI. IL-6 has been implicated in 579 neurodegeneration after central nervous system (CNS) injury, and the anti-inflammatory cytokine 580 IL-10 exhibits neuroprotective effects (Donnelly and Popovich 2008, Schmitz and Chew 2008, 581 Zhang et al. 2019 ). However, we did not find any significant cytokine changes between naïve and 582 sham mice within 7 days of injury, indicating that the laminectomy did not produce a significant 583 inflammatory response at the time points tested. As a positive control for the cytokine ELISAs 584 (Suzuki and Kikkawa 1969) , we used the cuprizone model for multiple sclerosis. Key pathological 585
features of the treatment include secretion of proinflammatory cytokines such as TNF-α and IL-586
1β (Schmitz and Chew 2008) . Consistent with previous findings, mice treated with cuprizone 587 exhibited significant increases in TNF-α, IL-1β, and IL-10 relative to naïve mice (Fig.1C Different types of sensory neurons are distinct in their responses to injury. It is likely that, even 616
within an identified subpopulation, cells will nonetheless exhibit heterogeneity (Hu, Huang, Hu, 617 Du, Xue, Zhu and Fan 2016). Because injury does not impact all afferents in the same way, we 618 analyzed gene expression changes within the population of nociceptors projecting to the skin 619 below the level of injury. By focusing on small nociceptors innervating dermatomes below the 620 level of injury, we begin to address what unique set of genes within a specific population may be 621
contributing to the burning, stabbing, and shooting pain reported in SCI patients suffering from 622 below-level neuropathic pain (Siddall, McClelland, Rutkowski and Cousins 2003) . Our goal was 623 to better understand how SCI affects molecular changes within a specific population of neurons, 624
and how this may contribute to hypersensitivity following SCI. We focused our analysis on sensory 625 neurons from lumbar DRGs (below the level of the SCI) projecting to the hairy hindpaw skin 626 Fig.2A ). After confirming we had isolated the cell population of interest (Fig.2B, Fig.3) , we used 627
RNAseq to identify changes in gene expression. The use of RNA-Seq has clear advantages over 628 microarrays, since RNA-Seq is not limited to a set of pre-determined transcripts, has a larger 629 dynamic range of transcript expression, and is highly reproducible (Usoskin, Furlan, Islam, Abdo, 630
Lonnerberg, Lou, Hjerling-Leffler, Haeggstrom, Kharchenko, Kharchenko, Linnarsson and 631
Ernfors 2015). By utilizing this technology, we were able to identify transcript changes 632 undetectable with traditional RT-PCR or microarrays (Wang and Zylka 2009). Our RNAseq data 633 from naïve, sham, and injured animals display distinct patterns of somatosensory genes present in 634 this nociceptor-enriched population. In particular, RPKM values show high levels of Scn10a (a 635 marker for nociceptors), purinergic receptor P2rx3, Mrgprd (markers for the non-peptidergic 636 population of nociceptors), and Calca and Calcb (neuropeptide precursors), indicating that we 637 isolated the desired nociceptor specific cell population, and also indicating important genes within 638 the population of sensory neurons projecting to the hairy hindpaw skin (Fig.4A-D) . Multiple gene 639 transcripts important for itch, tactile function, and proprioception all had relatively low RPKM 640
values, indicating again that we isolated the desired target cell population, and that injury did not 641 induce modifications in the type of stimuli nociceptors transduce (Fig.4C ). Our population level 642 analysis revealed significant changes after SCI in a number of ion channels and receptors that are 643 already known to play a role in pain or hypersensitivity, such as Piezo2, and transcripts involved 644 in excitatory signaling, such as Grik1 (Fig.5C, Table 1 ). However, there were also many genes 645 whose expression and functional roles in persistent pain have yet to be characterized, including 646
Trpc4 and Ttyh1 (Fig.5A,B , Table 1 Although previous screens have yielded various nociceptor-specific genes, we have identified a 656 unique pattern of gene expression within a population of nociceptors projecting to the periphery 657 ( Fig. 6) . By cross-comparing our data set with similar studies, we were able to identify our cells 658 of interest and confirm that we obtained cell-type specificity. Notably, many of the current 659 technologies require a transgenic mouse with a cell-type specific reporter. However, by taking 660 advantage of the anatomical organization of the mouse, we were able to use backlabeling and 661
FACS sorting in non-transgenic animals to isolate a nociceptor-enriched population with a low 662 degree of contamination with other cell types. We further implemented this methodology to 663 identify candidate genes in a specific population of neurons below the level of injury in a model 664 of SCI to better understand the heterogenous injury response among the many subtypes of DRG 665 neurons. 666 667
Among these comparisons we observed large fold changes in several genes (( Fig.7A,B) , 668
highlighted in red and blue). However, instead of focusing on larger changes in a small subset of 669 genes with individual functions, we concentrated our analysis on the interaction of many 670 transcripts that were significantly altered after SCI and how these influenced intracellular signaling 671 pathways (Fig.7C) . Ingenuity Pathway Analysis implicated numerous pathways associated with 672 the progression to persistent pain. We took particular interest in the synaptogenesis signaling 673 pathway as a key player at this 4 day time point, suggesting a role for synaptic plasticity in the 674 transition from acute to chronic pain after SCI. In addition to its relevance within our model, many 675 of the transcripts involved in synaptic plasticity overlapped with several other pathways (Fig.7C)  676 and had RPKM values that could be validated by qPCR (Fig.7D ). Synaptogenesis is typically 677 associated with developmental processes, including axon guidance and synapse formation (Klein 678 2004). However, activation of various signaling pathways involved in synaptogenesis may also 679 contribute to pain; for example persistent pain is supported via changes in synaptic signaling, 680 neuronal plasticity, and long term potentiation, and may form memory-like networks for painful 681 signals that allow persistent pain to occur long after the initial injury (Khangura et al. 2019, 682 Kobayashi et al. 2007 ). 683 684 Included in the many of the genes of interest within the synaptogenesis pathway, Ephb2 was 685 significantly down regulated post-injury ( Table 1) . The gene transcript is part of the Ephrin 686 tyrosine kinase receptor protein family that is expressed in laminae I-III of the spinal dorsal horn 687 on small and medium sized DRG neurons (presumably nociceptors) (Bundesen et al. 2003 We recognize that RNA-Seq of batched neurons elucidated changes in gene targets in a 722 subpopulation of cells, but averaging occurred when pooling large numbers of cells, precluding 723 analysis at the level of the single cell (Haque et al. 2017) . Further analysis at the single cell level 724 of cutaneous nociceptors will clarify the contributions of specific subpopulations (non-peptidergic 725 versus peptidergic) to chronic pain after SCI. Functional studies are also needed to analyze the 726 roles of this specific cell population, to better understand the connectivity and plasticity of the 727 CNS and PNS. While our results begin to address prospective gene networks that may contribute 728 to the development of chronic pain, additional behavioral testing in conjunction with targeting of 729 specific biological mechanisms until the chronic pain phase is necessary in order to attribute 730 specific transcriptional changes to pain phenotypes. The DRG nociceptor preparation isolated by 731 backlabeling with WGA-488 and FACS has many applications in molecular studies. We have 732 demonstrated how the cutaneous nociceptor transcriptome is altered following SCI to gain novel 733 biological insight into disease mechanisms in a cell-type specific approach. It is evident that the 734 transition from acute to chronic pain occurs in distinct steps that involve numerous signaling 735 pathways, providing a host of potential new drug targets. 736 737
Author Cytokine ELISAs on spinal cord segments at the level of laminectomy (T8-T11) show no 766 significant differences between naïve and sham mice 1 or 4 days post-surgery. 1-day post-767 operation, SCI mice have significantly increased levels of IL-6 and IL-10 compared to naïve 768 controls (one-way ANOVA, Bonferroni's multiple comparisons test; *p<0.05, **p<0.005, 769 respectively) and significantly increased levels of IL-10 in comparison to 4d sham condition (one-770 way ANOVA, Bonferroni's multiple comparisons test; ***p<0.001). Cuprizone treated mice as 771 positive control, with significantly increased TNF-α, IL-1β, and IL-10 compared to naïve controls 772 (one-way ANOVA, Bonferroni's multiple comparisons test; **p<0.005, **p<0.005, ***p<0.001, 773 respectively) after 5 weeks of cuprizone treatment and significant increases in IL-1β at the 1d sham 774 timepoint, and IL-10 at the 4d sham timepoint (one-way ANOVA, Bonferroni's multiple 775 comparisons test; *p<0.05, ****p<0.0001, respectively). * Represents comparisons to naïve 776 conditions, # represents comparisons to 1d sham conditions, ^ represents comparisons to 4d sham 777 conditions. 778 
